Guide for patients & caregivers
Hepatitis B e Antigen (HBeAg) Positive: What Does It Mean?
HBeAg positive explained: what hepatitis B e antigen says about viral activity and infectiousness, seroconversion, monitoring and questions for your specialist.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does HBeAg positive mean?
HBeAg positive means a protein called hepatitis B e antigen was found in your blood. The CDC links its presence with active viral replication, high levels of hepatitis B virus DNA and higher infectiousness. It is read alongside other hepatitis B markers, liver blood tests and history; on its own it does not measure liver damage or decide treatment.
This guide is for adults who already know they have hepatitis B, usually from a positive hepatitis B surface antigen (HBsAg) test, and now see an HBeAg result. It explains the terms in outline and cannot interpret an individual result. The basics of a positive HBsAg test, such as acute versus chronic infection and protecting household contacts, are covered in a separate guide.
Symptoms that need urgent care
Most people with hepatitis B have no symptoms between appointments. Some changes should not wait for a routine follow-up.
- Yellowing of the skin or the whites of the eyes (jaundice), which may come with itchy skin, darker urine or paler stools: NHS advises asking for an urgent GP appointment or getting help from NHS 111, or the equivalent urgent service where you live.
- Confusion or difficulty thinking, or swelling of the abdomen or ankles: NIDDK lists these among signs of cirrhosis. Seek prompt medical care, and emergency care if symptoms are severe or getting worse quickly.
- Any medical emergency: Healthdirect advises calling the local emergency number (000 in Australia) if you need urgent medical help.
How is HBeAg different from HBsAg, and is it more contagious?
Both are parts of the hepatitis B virus, but they answer different questions. HBsAg, the surface antigen, shows that the infection is present. The CDC states that anyone with HBsAg should be considered infectious, whether the infection is acute or chronic.
HBeAg adds information about how active the virus is. The CDC Pink Book describes it as a marker associated with a high number of infective virus particles in the blood. HBeAg can be found in both acute and chronic hepatitis B, so it does not tell you on its own which type you have.
CDC sources describe HBeAg as a marker of higher infectivity, because it tends to go with more virus in the blood. This is relevant to partners, household members and pregnancy planning.
An HBeAg-negative result does not make someone non-infectious, though. Anyone who is HBsAg positive can still pass on the virus. Vaccination of close contacts and everyday precautions are still advised whatever the HBeAg result; the positive HBsAg guide covers these steps.
What is HBeAg seroconversion?
Seroconversion means HBeAg disappears from the blood and an antibody against it, anti-HBe, appears. The CDC Pink Book says anti-HBe usually goes with less replicating virus and lower infectivity, although a return to HBeAg positivity can happen.
A review in the journal Viruses explains that after seroconversion people tend to follow one of two paths. Some have HBeAg-negative infection with the virus under good immune control. Others develop HBeAg-negative chronic hepatitis, often because of virus variants that make little or no e antigen. In that situation HBV DNA can stay high or rise and fall, with flares of liver inflammation.
This is why an HBeAg-negative result is not taken as an all-clear. HBV DNA and liver tests are usually followed over time to show which pattern applies.
Which tests are read together with HBeAg?
The 2023 CDC hepatitis B testing recommendations state that testing for HBeAg, anti-HBe and HBV DNA gives information on the level of viral replication and infectivity. HBV DNA is a direct measure of viral load. NIDDK explains that further tests help show whether the infection is acute or chronic, whether there is a higher chance of liver damage, whether virus levels are high or low and whether treatment is needed.
Liver checks usually include blood tests such as ALT, and NIDDK describes imaging and elastography, a test of liver stiffness, to look for scarring. A specialist combines these results rather than relying on any single marker.
Does a positive HBeAg mean I need treatment?
Not automatically. NIDDK states that not everyone with chronic hepatitis B needs treatment, and that antiviral medicines may be prescribed if blood tests show the virus could be damaging the liver.
The 2024 WHO hepatitis B guidelines base adult treatment mainly on significant liver scarring, an HBV DNA level above 2,000 IU/mL together with a raised ALT, and other factors such as coinfection with HIV, hepatitis C or hepatitis D, or a family history of liver cancer or cirrhosis. In that summary, HBeAg status matters most in pregnancy: WHO recommends antiviral prevention for pregnant women with HBV DNA of at least 200,000 IU/mL or a positive HBeAg, where these tests are available. Countries and specialist societies set their own criteria, so the local specialist applies the rules that fit you.
If you already take antiviral medicine, NIDDK advises not stopping it without first talking with your doctor. Do not stop or change any prescribed medicine on the basis of a new test result. Tell any doctor planning chemotherapy or other immune-suppressing treatment that you have hepatitis B, because NIDDK notes the virus can reactivate.
How is HBeAg-positive hepatitis B monitored?
Monitoring continues even when you feel well. Healthdirect says people who do not need treatment still need regular check-ups to watch for liver damage, and may need regular screening for liver cancer. NIDDK describes blood tests and an ultrasound or other imaging for that screening.
Repeat HBeAg, anti-HBe and HBV DNA results show whether the infection is changing, for example moving towards seroconversion. The CDC Pink Book notes that HBV DNA tests are also used to monitor response to treatment. If you are pregnant, NIDDK says your doctor will check virus levels, and your baby should receive the hepatitis B vaccine and hepatitis B immune globulin right after birth.
Questions to ask your specialist
These questions can help you leave the appointment with a clear plan.
- Is my HBeAg positive or negative, and is anti-HBe present?
- What is my HBV DNA level, and how does it compare with earlier results?
- What do my ALT and liver stiffness or scan results show?
- Which treatment criteria does this service use, and do I meet any of them now?
- How often will HBeAg, HBV DNA and liver tests be repeated, and who arranges them?
- Do I need liver cancer screening, and how often?
- If I am planning a pregnancy, what would change in my care?
How comparing similar cases on SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Seeing how other people tracked their HBeAg, anti-HBe and HBV DNA results over time, and which questions they asked their specialists, can help you organise your own results before an appointment. Similar cases cannot tell you what your infection will do or whether you need treatment; your specialist makes those decisions with your full results.
Sources and further reading
- CDC Pink Book: Hepatitis B chapter, serologic markers HBeAg and anti-HBe (May 2024)
- CDC MMWR: Screening and testing for hepatitis B virus infection, recommendations (2023)
- NIDDK: Hepatitis B, diagnosis, treatment and monitoring (reviewed December 2024)
- WHO 2024 chronic hepatitis B guidelines, executive summary (PMC text extract)
- Viruses (CC BY 4.0): HBeAg-negative/anti-HBe-positive chronic hepatitis B review (2022)
- Healthdirect Australia: Hepatitis B (reviewed December 2025)
- NHS: Jaundice and urgent medical advice (reviewed January 2024)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.